Prevest Denpro Ltd

Prevest Denpro Ltd (PREVEST) is a micro-cap Healthcare company valued at ₹486 crore operating in Medical Equipment on the NSE and BSE.

Recent price move

Prevest Denpro Ltd last traded at ₹405, modestly down 0.78% on the day.

Recent developments

On 2026-09-30, promoter holding was recorded at 73.60%, showing no change from the previous quarter. The company's latest quarterly results, ending 2026-06-30, showed strong growth in both revenue and net profit compared to the same quarter a year earlier.

Financial performance

The company's business is improving, with annual revenue rising 13.9% and net profit growing 12.8% year-over-year. The latest quarter saw revenue and net profit both rise significantly, with revenue up 20.9% and net profit up 27.9% compared to the same quarter a year earlier. However, the net profit margin narrowed slightly to 28.5% from 28.8% in the prior year.

Valuation multiples

The stock trades at 23.7 times earnings, a discount to the Healthcare median of 32.0, 3.63 times book value. It yields 0.3%.

Things to watch

The stock is 25.8% below its 52-week high, indicating a significant pullback from recent peak levels. The net profit margin has narrowed by 0.3 percentage points, which could signal pressure on profitability despite revenue growth.

Where it stands

Prevest Denpro Ltd has shown consistent revenue and profit growth over the past five years, with the latest quarter reflecting strong performance. The company remains almost debt-free and has a high promoter holding, but the stock is currently trading below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.